Myoinositol Improves Embryo Development in PCOS Patients Undergoing ICSI

Table 2

Embryo development times and parameters levels.

		PCOS patients treated with folic acid (group I)				PCOS patients treated with myoinositol plus folic acid (group II)				Patients without PCOS (group III)
		E2	Progesterone on the day of ovulation induction	SOD	Catalase	E2	Progesterone on the day of ovulation induction	SOD	Catalase	E2	Progesterone on the day of ovulation induction	SOD	Catalase
		−0.164	0.038	−0.484	0.082	−0.358	0.128	−0.036	0.293	−0.055	−0.055	−0.001	0.376
		0.210	0.775	<0.001	0.533	0.009	0.366	0.801	0.035	0.579	0.581	0.993	<0.001
		−0.130	0.284	0.402	0.036	−0.146	0.273	−0.092	0.190	−0.057	0.085	−0.093	0.400
		0.323	0.028	0.001	0.787	0.303	0.050	0.515	0.178	0.561	0.390	0.343	<0.001
		−0.316	−0.122	−0.408	0.338	−0.365	−0.309	0.154	0.627	−0.084	0.137	−0.016	0.159
		0.014	0.352	0.001	0.008	0.008	0.026	0.276	<0.001	0.392	0.163	0.868	0.106
		0.028	−0.041	−0.053	−0.014	0.234	0.159	0.120	0.043	−0.136	0.086	−0.335	−0.137
		0.831	0.758	0.689	0.915	0.096	0.260	0.396	0.765	0.168	0.382	<0.001	0.162

This table shows only the significant correlations between embryo development times and the level of oestradiol and progesterone in serum and SOD and CAT in follicular fluid.